MediciNova forms a JV with Zhejiang Medicine Co.named Zhejiang Sunmy Medicine Biotechnology Corp. Ltd to develop and commercialize MN-221 for asthma in China

MediciNova Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Zhejiang Medicine Co. Ltd.

China / Small-Cap Biopharma (<$1 billion)

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced